SL
LLY icon

Sentinus LLC’s Eli Lilly LLY Stock Holding History

Sentinus LLC’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.26M Buy
2,720
+649
+31% +$663K 0.26% 93
2026
Q1 		$1.9M Buy
2,071
+894
+76% +$906K 0.17% 114
2025
Q4 		$1.27M Buy
1,177
+354
+43% +$338K 0.12% 148
2025
Q3 		$628K Buy
823
+55
+7% +$40.9K 0.14% 105
2025
Q2 		$599K Buy
768
+52
+7% +$40.4K 0.15% 108
2025
Q1 		$591K Buy
716
+142
+25% +$118K 0.17% 96
2024
Q4 		$443K Buy
574
+55
+11% +$45.5K 0.13% 115
2024
Q3 		$460K Buy
519
+77
+17% +$69.2K 0.14% 118
2024
Q2 		$401K Buy
442
+21
+5% +$16.8K 0.13% 117
2024
Q1 		$328K Buy
+421
New +$300K 0.12% 123

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sentinus LLC's LLY Position: Q2 2026 in Review

Sentinus LLC increased its Eli Lilly (LLY) stake by 31% in Q2 2026, buying an estimated $663K and bringing the position to 2,720 shares worth $3.26M. The position accounts for 0.26% of the portfolio, ranked #93.

Sentinus LLC first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Sentinus LLC held 2,720 shares of Eli Lilly worth $3.26M as of Q2 2026.
  • Sentinus LLC bought 649 Eli Lilly shares in Q2 2026, an estimated $663K.
  • Eli Lilly made up 0.26% of Sentinus LLC's portfolio in Q2 2026, its #93 holding.
  • Sentinus LLC first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Sentinus LLC's 13F filing for Q2 2026, filed 11 Aug 2026.